TY - JOUR
T1 - Editor's Choice – Infrapopliteal Peripheral Vascular Interventions for Claudication are Performed Frequently in the USA and Are Associated with Poor Long Term Outcomes
AU - Bose, Sanuja
AU - Dun, Chen
AU - Solomon, Alex J.
AU - Black, James H.
AU - Conte, Michael S.
AU - Kalbaugh, Corey A.
AU - Woo, Karen
AU - Makary, Martin A.
AU - Hicks, Caitlin W.
N1 - Publisher Copyright:
© 2024 European Society for Vascular Surgery
PY - 2025/1
Y1 - 2025/1
N2 - Objective: Infrapopliteal peripheral vascular interventions (PVIs) for claudication are still performed in the USA. This study aimed to evaluate whether infrapopliteal PVI is associated with worse long term outcomes than isolated femoropopliteal PVI for treatment of claudication. Methods: A retrospective analysis of fee for service claims in a national administrative database was conducted using 100% of the Medicare fee for service claims between 2017 and 2019 to capture all Medicare beneficiaries who underwent an index infra-inguinal PVI for claudication. Hierarchical Cox proportional hazards models were performed to assess the association of infrapopliteal PVI with conversion to chronic limb threatening ischaemia (CLTI), repeat PVI, and major amputation. Results: In total, 36 147 patients (41.1% female; 89.7% age ≥ 65 years; 79.0% non-Hispanic White ethnicity) underwent an index PVI for claudication, of whom 32.6% (n = 11 790) received an infrapopliteal PVI. Of these, 61.4% (n = 7 245) received a concomitant femoropopliteal PVI and 38.6% (n = 4 545) received an isolated infrapopliteal PVI. The median follow up time was 3.5 years (interquartile range 2.7, 4.3). Patients receiving infrapopliteal PVI had a higher three year cumulative incidence of conversion to CLTI (26.0%; 95% confidence interval [CI] 24.9 – 27.2% vs. 19.9%; 95% CI 19.1 – 20.7%), repeat PVI (56.0%; 95% CI 54.8 – 57.3% vs. 45.7%; 95% CI 44.9 – 46.6%), and major amputation (2.2%; 95% CI 1.8 – 2.6% vs. 1.3%; 95% CI 1.1 – 1.5%) compared with patients receiving isolated femoropopliteal PVI. After adjusting for patient and physician level characteristics, the risk of conversion to CLTI (adjusted hazard ratio [aHR] 1.31, 95% CI 1.23 – 1.39), repeat PVI (aHR 1.12, 95% CI 1.05 – 1.20), and major amputation (aHR 1.72, 95% CI 1.42 – 2.07) remained significantly higher for patients receiving infrapopliteal PVI. An increasing number of infrapopliteal vessels treated during the index intervention was associated with increasingly poor outcomes (p < .001 for trend). Conclusion: Infrapopliteal PVI for claudication is associated with worse long term outcomes relative to isolated femoropopliteal PVI.
AB - Objective: Infrapopliteal peripheral vascular interventions (PVIs) for claudication are still performed in the USA. This study aimed to evaluate whether infrapopliteal PVI is associated with worse long term outcomes than isolated femoropopliteal PVI for treatment of claudication. Methods: A retrospective analysis of fee for service claims in a national administrative database was conducted using 100% of the Medicare fee for service claims between 2017 and 2019 to capture all Medicare beneficiaries who underwent an index infra-inguinal PVI for claudication. Hierarchical Cox proportional hazards models were performed to assess the association of infrapopliteal PVI with conversion to chronic limb threatening ischaemia (CLTI), repeat PVI, and major amputation. Results: In total, 36 147 patients (41.1% female; 89.7% age ≥ 65 years; 79.0% non-Hispanic White ethnicity) underwent an index PVI for claudication, of whom 32.6% (n = 11 790) received an infrapopliteal PVI. Of these, 61.4% (n = 7 245) received a concomitant femoropopliteal PVI and 38.6% (n = 4 545) received an isolated infrapopliteal PVI. The median follow up time was 3.5 years (interquartile range 2.7, 4.3). Patients receiving infrapopliteal PVI had a higher three year cumulative incidence of conversion to CLTI (26.0%; 95% confidence interval [CI] 24.9 – 27.2% vs. 19.9%; 95% CI 19.1 – 20.7%), repeat PVI (56.0%; 95% CI 54.8 – 57.3% vs. 45.7%; 95% CI 44.9 – 46.6%), and major amputation (2.2%; 95% CI 1.8 – 2.6% vs. 1.3%; 95% CI 1.1 – 1.5%) compared with patients receiving isolated femoropopliteal PVI. After adjusting for patient and physician level characteristics, the risk of conversion to CLTI (adjusted hazard ratio [aHR] 1.31, 95% CI 1.23 – 1.39), repeat PVI (aHR 1.12, 95% CI 1.05 – 1.20), and major amputation (aHR 1.72, 95% CI 1.42 – 2.07) remained significantly higher for patients receiving infrapopliteal PVI. An increasing number of infrapopliteal vessels treated during the index intervention was associated with increasingly poor outcomes (p < .001 for trend). Conclusion: Infrapopliteal PVI for claudication is associated with worse long term outcomes relative to isolated femoropopliteal PVI.
KW - Endovascular
KW - Endovascular procedure
KW - Intermittent claudication
KW - Peripheral arterial disease
KW - Tibial arteries
UR - https://www.scopus.com/pages/publications/85199535525
UR - https://www.scopus.com/pages/publications/85199535525#tab=citedBy
U2 - 10.1016/j.ejvs.2024.06.017
DO - 10.1016/j.ejvs.2024.06.017
M3 - Article
C2 - 38906366
AN - SCOPUS:85199535525
SN - 1078-5884
VL - 69
SP - 89
EP - 101
JO - European Journal of Vascular and Endovascular Surgery
JF - European Journal of Vascular and Endovascular Surgery
IS - 1
ER -